G Losonsky

2.1k total citations
31 papers, 1.6k citations indexed

About

G Losonsky is a scholar working on Endocrinology, Food Science and Infectious Diseases. According to data from OpenAlex, G Losonsky has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, 14 papers in Food Science and 13 papers in Infectious Diseases. Recurrent topics in G Losonsky's work include Salmonella and Campylobacter epidemiology (14 papers), Viral gastroenteritis research and epidemiology (13 papers) and Vibrio bacteria research studies (13 papers). G Losonsky is often cited by papers focused on Salmonella and Campylobacter epidemiology (14 papers), Viral gastroenteritis research and epidemiology (13 papers) and Vibrio bacteria research studies (13 papers). G Losonsky collaborates with scholars based in United States, Switzerland and Chile. G Losonsky's co-authors include Myron M. Levine, Fernando Noriega, M. M. Levine, James P. Nataro, Marcelo B. Sztein, Robert Edelman, Carol O. Tacket, C O Tacket, Karen L. Kotloff and A. Marshall McBean and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Microbiology.

In The Last Decade

G Losonsky

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Losonsky United States	24	811	772	488	364	226	31	1.6k
Orntipa Sethabutr Thailand	21	866 1.1×	1.1k 1.4×	534 1.1×	106 0.3×	143 0.6×	41	1.9k
G Losonsky United States	22	1.9k 2.4×	994 1.3×	798 1.6×	613 1.7×	325 1.4×	24	2.6k
A.‐M. Svennerholm Sweden	28	1.3k 1.6×	702 0.9×	300 0.6×	439 1.2×	175 0.8×	50	1.9k
John L. VanCott United States	22	226 0.3×	751 1.0×	173 0.4×	618 1.7×	159 0.7×	29	1.6k
Frank Verdonck Belgium	24	466 0.6×	511 0.7×	221 0.5×	393 1.1×	317 1.4×	54	1.6k
Tobias Schlapp Germany	19	304 0.4×	382 0.5×	119 0.2×	179 0.5×	170 0.8×	29	991
Antoinette B. Hartman United States	20	776 1.0×	697 0.9×	231 0.5×	364 1.0×	217 1.0×	34	1.4k
D H Burr United States	17	435 0.5×	747 1.0×	959 2.0×	123 0.3×	140 0.6×	21	1.4k
Robert W. Kaminski United States	24	895 1.1×	932 1.2×	163 0.3×	339 0.9×	237 1.0×	57	1.5k
Christian Menge Germany	21	533 0.7×	664 0.9×	151 0.3×	161 0.4×	135 0.6×	76	1.2k

Countries citing papers authored by G Losonsky

Since Specialization

Citations

This map shows the geographic impact of G Losonsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Losonsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Losonsky more than expected).

Fields of papers citing papers by G Losonsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Losonsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Losonsky. The network helps show where G Losonsky may publish in the future.

Co-authorship network of co-authors of G Losonsky

This figure shows the co-authorship network connecting the top 25 collaborators of G Losonsky. A scholar is included among the top collaborators of G Losonsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Losonsky. G Losonsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tacket, C O, Karen L. Kotloff, G Losonsky, et al.. (1997). Volunteer Studies Investigating the Safety and Efficacy of Live Oral El Tor Vibrio cholerae O1 Vaccine Strain CVD 111. American Journal of Tropical Medicine and Hygiene. 56(5). 533–537. 42 indexed citations

Taylor, David N., C O Tacket, G Losonsky, et al.. (1997). Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infection and Immunity. 65(9). 3852–3856. 40 indexed citations

Levine, Orin S., Rosanna Lagos, G Losonsky, et al.. (1996). No Adverse Impact on Protection against Pertussis from Combined Administration of Haemophilus infiuenzae Type b Conjugate and Diphtheria-Tetanus Toxoid-Pertussis Vaccines in the Same Syringe. The Journal of Infectious Diseases. 174(6). 1341–1344. 6 indexed citations

Morris, J. Glenn, Marcelo B. Sztein, Eugene W. Rice, et al.. (1996). Vibrio cholerae 01 Can Assume a Chlorine-Resistant Rugose Survival Form that Is Virulent for Humans. The Journal of Infectious Diseases. 174(6). 1364–1368. 92 indexed citations

Noriega, Fernando, et al.. (1996). Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine. Infection and Immunity. 64(8). 3055–3061. 80 indexed citations

Barry, Eileen M., Oscar G. Gómez‐Duarte, S Chatfield, et al.. (1996). Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infection and Immunity. 64(10). 4172–4181. 58 indexed citations

Noriega, Fernando, et al.. (1996). Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Infection and Immunity. 64(1). 23–27. 50 indexed citations

Losonsky, G, et al.. (1996). Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. Infection and Immunity. 64(1). 10–15. 52 indexed citations

González-Bonilla, César, David M. Hone, Fernando Noriega, et al.. (1994). Salmonella typhi Vaccine Strain CVD 908 Expressing the Circumsporozoite Protein of Plasmodium falciparum: Strain Construction and Safety and Immunogenicity in Humans. The Journal of Infectious Diseases. 169(4). 927–931. 103 indexed citations

10.

Tacket, Carol O., G Losonsky, James P. Nataro, et al.. (1993). Safety and Immunogenicity of Live Oral Cholera Vaccine Candidate CVD 110, a ctxA ctxAzot zotace Derivative of El Tor Ogawa Vibrio cholerae. The Journal of Infectious Diseases. 168(6). 1536–1540. 79 indexed citations

11.

Edelman, Robert, S L Hoffman, Jonathan R. Davis, et al.. (1993). Long-Term Persistence of Sterile Immunity in a Volunteer Immunized with X-Irradiated Plasmodium falciparum Sporozoites. The Journal of Infectious Diseases. 168(4). 1066–1070. 60 indexed citations

12.

Hone, David M., Carol O. Tacket, Andrea M. Harris, et al.. (1992). Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.. Journal of Clinical Investigation. 90(2). 412–420. 67 indexed citations

13.

Padilla-Noriega, Luis, Lucia Fiore, Margaret B. Rennels, et al.. (1992). Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus. Journal of Clinical Microbiology. 30(6). 1392–1397. 19 indexed citations

14.

Tacket, Carol O., G Losonsky, David N. Taylor, et al.. (1991). Lack of Immune Response to the Vi Component of a Vi-Positive Variant of the Salmonella typhi Live Oral Vaccine Strain Ty21a in Human Studies. The Journal of Infectious Diseases. 163(4). 901–904. 26 indexed citations

15.

Onorato, Ida M., John F. Modlin, A. Marshall McBean, et al.. (1991). Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines. The Journal of Infectious Diseases. 163(1). 1–6. 176 indexed citations

16.

Losonsky, G. (1991). Infections associated with swimming and diving.. PubMed. 18(3). 181–5. 5 indexed citations

17.

Morris, J. Glenn, Tae Takeda, Ben D. Tall, et al.. (1990). Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.. Journal of Clinical Investigation. 85(3). 697–705. 84 indexed citations

18.

Murillo, Jorge, et al.. (1989). EFFECT OF PRIMING WITH CARRIER ON RESPONSE TO CONJUGATE VACCINE. The Lancet. 334(8677). 1415–1418. 70 indexed citations

19.

Mm, Levine, James B. Kaper, D A Herrington, et al.. (1988). The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.. PubMed. 19(3). 401–15. 3 indexed citations

20.

Losonsky, G, et al.. (1986). Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants. The Pediatric Infectious Disease Journal. 5(1). 25–29. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact